Immuneering Corp Net Income Loss

Quick Answer

Immuneering Corp reported Net Income Loss of -$56.02 million for the year ending 2025.

  • Immuneering Corp showed an increase of +8.2% in Net Income Loss from 2024 to 2025.
  • This data is from Immuneering Corp's annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Immuneering Corp's Net Income Loss has declined by 228.8%.
  • Historical annual values: Fiscal year 2025: -$56.02 million | Fiscal year 2024: -$61.04 million | Fiscal year 2023: -$53.47 million | Fiscal year 2022: -$50.51 million | Fiscal year 2021: -$33.54 million | Fiscal year 2020: -$17.04 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: